IT201700076321A1 - COMPOSITIONS CONTAINING L-ACETYLCARNITINE FOR THE USE IN THE TREATMENT OF PAINFUL SYMPTOMS ASSOCIATED WITH THE SHOULDERS OF THE SHOULDER - Google Patents

COMPOSITIONS CONTAINING L-ACETYLCARNITINE FOR THE USE IN THE TREATMENT OF PAINFUL SYMPTOMS ASSOCIATED WITH THE SHOULDERS OF THE SHOULDER

Info

Publication number
IT201700076321A1
IT201700076321A1 IT102017000076321A IT201700076321A IT201700076321A1 IT 201700076321 A1 IT201700076321 A1 IT 201700076321A1 IT 102017000076321 A IT102017000076321 A IT 102017000076321A IT 201700076321 A IT201700076321 A IT 201700076321A IT 201700076321 A1 IT201700076321 A1 IT 201700076321A1
Authority
IT
Italy
Prior art keywords
acetylcarnitine
shoulders
shoulder
treatment
compositions containing
Prior art date
Application number
IT102017000076321A
Other languages
Italian (it)
Inventor
Maurizio Luigi Modini
Renato Cricchio
Original Assignee
Mm Farma Srl Semplificata A Socio Unico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mm Farma Srl Semplificata A Socio Unico filed Critical Mm Farma Srl Semplificata A Socio Unico
Priority to IT102017000076321A priority Critical patent/IT201700076321A1/en
Publication of IT201700076321A1 publication Critical patent/IT201700076321A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
IT102017000076321A 2017-07-06 2017-07-06 COMPOSITIONS CONTAINING L-ACETYLCARNITINE FOR THE USE IN THE TREATMENT OF PAINFUL SYMPTOMS ASSOCIATED WITH THE SHOULDERS OF THE SHOULDER IT201700076321A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102017000076321A IT201700076321A1 (en) 2017-07-06 2017-07-06 COMPOSITIONS CONTAINING L-ACETYLCARNITINE FOR THE USE IN THE TREATMENT OF PAINFUL SYMPTOMS ASSOCIATED WITH THE SHOULDERS OF THE SHOULDER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000076321A IT201700076321A1 (en) 2017-07-06 2017-07-06 COMPOSITIONS CONTAINING L-ACETYLCARNITINE FOR THE USE IN THE TREATMENT OF PAINFUL SYMPTOMS ASSOCIATED WITH THE SHOULDERS OF THE SHOULDER

Publications (1)

Publication Number Publication Date
IT201700076321A1 true IT201700076321A1 (en) 2019-01-06

Family

ID=60628020

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000076321A IT201700076321A1 (en) 2017-07-06 2017-07-06 COMPOSITIONS CONTAINING L-ACETYLCARNITINE FOR THE USE IN THE TREATMENT OF PAINFUL SYMPTOMS ASSOCIATED WITH THE SHOULDERS OF THE SHOULDER

Country Status (1)

Country Link
IT (1) IT201700076321A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150148429A1 (en) * 2011-11-11 2015-05-28 Nova Neura, Llc Pain Relieving System

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150148429A1 (en) * 2011-11-11 2015-05-28 Nova Neura, Llc Pain Relieving System

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LEWIS J S ET AL: "Rotator Cuff Tendinopathy: Is There a Role for Polyunsaturated Fatty Acids and Antioxidants?", JOURNAL OF HAND THERAPY, HANLEY AND BELFUS, US, vol. 22, no. 1, 1 January 2009 (2009-01-01), pages 49 - 56, XP025881670, ISSN: 0894-1130, [retrieved on 20080830], DOI: 10.1197/J.JHT.2008.06.007 *

Similar Documents

Publication Publication Date Title
LTC3057969I2 (en) COMPOSITIONS USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH KIT
CL2018001624A1 (en) Polycyclic antagonists of tlr7 / 8 and their use in the treatment of immune disorders
CO2019001193A2 (en) Methods and compositions for the treatment of epileptic disorders
CL2016000807A1 (en) Amino heteroaryl benzamides as kinase inhibitors.
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
CR20150436A (en) NEW OCTAHIDRO-PIRROLO [3,4-C] -PIRROL AND -PIRIDINA-FENILO
DOP2015000246A (en) DERIVATIVES OF REPLACED OXOPIRIDINE AND USES OF THE SAME IN THE TREATMENT OF CARDIOVASCULAR DISORDERS
DOP2015000219A (en) HETEROARILO COMPOUNDS AND ITS USES
EA201692529A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DISORDERS USING FOLLYSTATINE POLYPEPTIDES
ECSP16012582A (en) HETEROCYCLIC COMPOUNDS AND METHODS OF USE
CL2016002389A1 (en) Compounds derived from amidopyridine, inverse agonist of the cannabinoid receptor type 2 pharmaceutical composition procedure of preparation and use of the compounds in the treatment or prophylaxis of neuropathic pain, asthma, osteoporosis, inflammation, among others.
GT201600027A (en) RORC2 INHIBITORS AND THEIR METHODS OF USE
IT201600084470A1 (en) Composition for use in the treatment of major depressive disorder
IT201600101413A1 (en) Liquid composition for use in the treatment of gastroesophageal reflux
PH12018502274A1 (en) Semaglutide in cardiovascular conditions
SMT201600102B (en) TRITOQUALINA FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS
BR112017009000A2 (en) apilimod for use in the treatment of melanoma
CR20150653A (en) NEW COMPOUNDS FOR CANCER TREATMENT
DOP2015000176A (en) AZETIDINYLOXYPHENYLPIRROLIDINE COMPOUNDS
PH12016500495A1 (en) Compositions for the treatment of hypertension and/or fibrosis
BR112015024625A2 (en) galactooligosaccharide composition for use in the prevention or treatment of cognitive dysfunction and emotional disorders in neuropsychiatric disorders or aging
ITUA20162350A1 (en) COMPOSITION TO DECOLORATE THE KERATIN FIBER
IT201600130012A1 (en) Composition for use in the treatment of disorders of the urogenital system
EA201590615A1 (en) STIMULATING LACTATION COMPOSITIONS BASED ON PHOSPHATIDIDILSERIN
CL2016000024A1 (en) Volasertib in combination with decitabine for the treatment of acute myeloid leukemia and myelodysplastic syndrome.